MedPath

Radiofrequency ablation of genicular nerve versus saphenous nerve for chronic knee pain

Not yet recruiting
Conditions
Osteoarthritis of knee,
Registration Number
CTRI/2019/03/018069
Lead Sponsor
ESI Institute of Pain Management
Brief Summary

This is a prospectiverandomized study to compare the efficacy of genicular nerve and saphenous nerve pulsed radiofrequency ablation (PRFA) for the relief of chronic knee pain. After obtaining proper informed consent, and maintaining theinclusion and exclusion criteria, 30 patients, over one year of study period there will be diagnostic block followed by PRFA proceduredividing the study population in two separate groups. Assessment of durationand quality of pain relief will be done followed by calculation by applying aspecific formula mentioned, and will be expressed appropriately.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1)Age between 25 and 65 years.
  • 2)Chronic knee pain (more than 3 months duration).
  • 3)Intensity of pain more than 4 according to VAS.
  • 4)Pain predominantly involving medial compartment of knee joint.
Exclusion Criteria
  • 1)Neurological deficit in lower limbs.
  • 2)Prior knee replacement surgery any surgery with prosthesis implantation.
  • 3)Diagnosed tumour or cancer involving knee.
  • 4)Primary or metastatic spine tumor or spinal cord injury.
  • 5)Leg pain due to PIVD.
  • 6)Allergy to medications used in procedure.
  • 7)Blood coagulation disorder.
  • 8)Pregnancy.
  • 9)Psychiatric illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Pain in VAS ScorePre procedure and at 2 weeks, 6 weeks, 12 weeks and at 20 weeks post PRF treatment.
2) Functional improvement in WOMAC scorePre procedure and at 2 weeks, 6 weeks, 12 weeks and at 20 weeks post PRF treatment.
Secondary Outcome Measures
NameTimeMethod
Duration of Pain reliefPre procedure and at 2 weeks, 6 weeks, 12 weeks and at 20 weeks post PRF treatment.

Trial Locations

Locations (1)

ESI Hospital, Sealdah

🇮🇳

Kolkata, WEST BENGAL, India

ESI Hospital, Sealdah
🇮🇳Kolkata, WEST BENGAL, India
Dr Subrata Goswami
Principal investigator
09830430430
drsgoswami@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.